Assessing heart risks in lung cancer patients undergoing treatment
Risk prediction and longitudinal assessment of cardiotoxicity and functional capacity trajectory in NSCLC patients
This study is looking at how different types of radiation used to treat non-small cell lung cancer might affect your heart, especially if you already have heart issues, so we can find ways to keep your heart healthy while you receive treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11103198 on NIH RePORTER |
What this research studies
This research focuses on non-small cell lung cancer (NSCLC) patients and aims to predict the risk of heart damage caused by radiation therapy. It evaluates how different types of radiation, such as photons and protons, can affect cardiac health, particularly in patients with pre-existing heart conditions. By analyzing individual risk factors and optimizing radiation doses, the study seeks to minimize cardiac toxicity during cancer treatment. Patients will be monitored over time to assess their heart function and overall health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with non-small cell lung cancer who are about to undergo radiation therapy.
Not a fit: Patients with lung cancer who are not receiving radiation therapy or those with advanced heart disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer radiation therapy options for lung cancer patients, reducing the risk of heart damage.
How similar studies have performed: Previous research has shown promising results in optimizing radiation therapy to reduce side effects, but this specific approach focusing on NSCLC and cardiac risk is relatively novel.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Liao, Zhongxing — University of Tx Md Anderson Can Ctr
- Study coordinator: Liao, Zhongxing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.